ARQT- Arcutis Biotherapeutics, Inc.

Name: Arcutis Biotherapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Arcutis Biotherapeutics, Inc. (ARQT) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. ARQT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Watanabe Todd	740.5K	$19.74M	-
Other	Edwards Larry Todd	150.2K	$4.00M	-
Other	Matsuda Masaru	127.6K	$3.40M	-
Other	Burnett Patrick	120.2K	$3.21M	-
CFO	Vairavan Latha	86.0K	$2.29M	-

Activity

Buys and sells only

Transactions

10 filings · page 14

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 14, 2023	Watanabe Todd Franklin65	See Remarks	Sell	1,000	$17.01	$17,011.76	-	-39.4%	-55.4%
Feb 1, 2023	Watanabe Todd Franklin65	See Remarks	Sell	1,000	$17.00	$17,002.72	-0.1%	-15.6%	-60.6%
Jan 17, 2023	Welgus Howard G.61	-	Sale+OE	8,500	$13.72	$116,654.85	-4.9%	-4.7%	-77.2%
Jan 3, 2023	Burnett Patrick	See Remarks	Sell	1,475	$15.01	$22,136.06	-3.4%	-24.5%	-73.5%
Dec 7, 2022	Watanabe Todd Franklin65	See Remarks	Sell	1,000	$17.06	$17,060.00	-0.3%	-19.3%	-87.0%
Nov 21, 2022	Matsuda Masaru51	See Remark	Sell	1,720	$18.19	$31,288.86	-8.1%	-11.1%	-89.6%
Nov 15, 2022	Welgus Howard G.61	-	Sale+OE	3,403	$20.01	$68,102.54	-2.0%	-13.4%	-89.3%
Nov 7, 2022	Watanabe Todd Franklin65	See Remarks	Sell	1,000	$18.00	$18,004.00	-0.3%	-10.8%	-87.3%
Oct 7, 2022	Watanabe Todd Franklin65	President And CEO	Sell	1,000	$19.51	$19,510.00	-0.3%	-21.1%	-75.5%
Oct 4, 2022	Welgus Howard G.61	Director	Sell	6,000	$20.29	$121,766.40	-3.4%	-27.6%	-77.9%

← PrevPage 14Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC